EP Biocomposites Limited (BOM:543595)
India · Delayed Price · Currency is INR 105.35
0.00 (0.00%)
At close: Jun 15, 2026
EP Biocomposites Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 136.4 | 120.06 | 114.39 | 71.31 | 80.6 |
| 136.4 | 120.06 | 114.39 | 71.31 | 80.6 | |
Revenue Growth (YoY) | 13.61% | 4.96% | 60.42% | -11.52% | 173.39% |
Cost of Revenue | 86.48 | 77.48 | 75.25 | 41.22 | 49.76 |
Gross Profit | 49.92 | 42.59 | 39.15 | 30.09 | 30.84 |
Selling, General & Admin | 17.39 | 18.68 | 19.1 | 15.95 | 12.96 |
Other Operating Expenses | 8.74 | 5.34 | 3.72 | 3.42 | 4.05 |
Operating Expenses | 27.15 | 25.14 | 23.82 | 20.36 | 17.67 |
Operating Income | 22.77 | 17.45 | 15.33 | 9.72 | 13.17 |
Interest Expense | -3.4 | -3.55 | -0.35 | -2.03 | -1.56 |
Interest & Investment Income | - | 0.28 | 0.73 | 0.45 | 0.06 |
Other Non Operating Income (Expenses) | - | - | - | -0 | - |
EBT Excluding Unusual Items | 19.37 | 14.17 | 15.71 | 8.14 | 11.66 |
Gain (Loss) on Sale of Assets | - | -0 | - | - | - |
Pretax Income | 19.37 | 14.17 | 15.71 | 8.14 | 11.66 |
Income Tax Expense | 4.79 | 3.86 | 4.21 | 2.38 | 3.57 |
Net Income | 14.58 | 10.31 | 11.5 | 5.76 | 8.09 |
Net Income to Common | 14.58 | 10.31 | 11.5 | 5.76 | 8.09 |
Net Income Growth | 41.47% | -10.34% | 99.57% | -28.82% | 126.09% |
Shares Outstanding (Basic) | 2 | 2 | 2 | 1 | 1 |
Shares Outstanding (Diluted) | 2 | 2 | 2 | 1 | 1 |
Shares Change (YoY) | 0.03% | - | 15.13% | 71.17% | 127.55% |
EPS (Basic) | 8.67 | 6.13 | 6.84 | 3.94 | 9.49 |
EPS (Diluted) | 8.67 | 6.13 | 6.84 | 3.94 | 9.48 |
EPS Growth | 41.44% | -10.35% | 73.54% | -58.44% | -0.70% |
Free Cash Flow | 14.02 | -5.11 | -14.8 | -8.17 | -47.55 |
Free Cash Flow Per Share | 8.34 | -3.04 | -8.80 | -5.59 | -55.72 |
Gross Margin | 36.60% | 35.47% | 34.22% | 42.19% | 38.26% |
Operating Margin | 16.70% | 14.53% | 13.40% | 13.63% | 16.34% |
Profit Margin | 10.69% | 8.59% | 10.05% | 8.08% | 10.04% |
Free Cash Flow Margin | 10.28% | -4.26% | -12.94% | -11.45% | -58.99% |
EBITDA | 23.78 | 18.57 | 16.33 | 10.72 | 13.83 |
EBITDA Margin | 17.44% | 15.47% | 14.28% | 15.03% | 17.16% |
D&A For EBITDA | 1.01 | 1.13 | 1.01 | 1 | 0.66 |
EBIT | 22.77 | 17.45 | 15.33 | 9.72 | 13.17 |
EBIT Margin | 16.70% | 14.53% | 13.40% | 13.63% | 16.34% |
Effective Tax Rate | 24.73% | 27.26% | 26.79% | 29.22% | 30.58% |
Revenue as Reported | 137.81 | 121.15 | 117.38 | 72.97 | 80.76 |
Advertising Expenses | - | 0.29 | 0.29 | 0.19 | 0.11 |